$49.66 0.2%
NARI Stock Price vs. AI Score
Data gathered: November 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Inari Medical (NARI)

Analysis generated May 22, 2024. Powered by Chat GPT.

Inari Medical is a company specializing in the medical technology field focusing on treatments for venous diseases. The company is renowned for its innovative and minimally invasive products designed to address two main conditions: venous thromboembolism and deep vein thrombosis. Inari Medical has been growing steadily, leveraging its technological expertise to gain a significant market share in the healthcare sector.

Read full AI stock Analysis

Stock Alerts - Inari Medical (NARI)

company logo Inari Medical | November 21
Insider Alert: Hoffman William is selling shares
company logo Inari Medical | November 20
Price is down by -5% in the last 24h.
company logo Inari Medical | November 12
Business Outlook among employees is up by 5.9% over the last month.
company logo Inari Medical | November 6
Price is up by 5.3% in the last 24h.

About Inari Medical

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States.


Inari Medical
Price $49.66
Target Price Sign up
Volume 608,820
Market Cap $2.87B
Year Range $37.11 - $58.62
Dividend Yield 0%
Analyst Rating 58% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24153M131M134M-18M-11M-0.090
Q2 '24146M24M122M-31M-11M-0.380
Q1 '24143M127M124M-24M-14M-0.220
Q4 '23129M120M115M-4.7M560,000-0.080
Q3 '23127M103M112M3.2M7.8M0.050

Insider Transactions View All

Hoffman William filed to sell 558,233 shares at $50.1.
November 20 '24
Hoffman William filed to sell 521,233 shares at $52.1.
November 20 '24
Hoffman William filed to sell 501,233 shares at $51.2.
November 20 '24
Hoffman William filed to sell 510,983 shares at $50.6.
November 20 '24
Hoffman William filed to sell 524,449 shares at $51.3.
November 20 '24

What is the Market Cap of Inari Medical?

The Market Cap of Inari Medical is $2.87B.

What is the current stock price of Inari Medical?

Currently, the price of one share of Inari Medical stock is $49.66.

How can I analyze the NARI stock price chart for investment decisions?

The NARI stock price chart above provides a comprehensive visual representation of Inari Medical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Inari Medical shares. Our platform offers an up-to-date NARI stock price chart, along with technical data analysis and alternative data insights.

Does NARI offer dividends to its shareholders?

As of our latest update, Inari Medical (NARI) does not offer dividends to its shareholders. Investors interested in Inari Medical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Inari Medical?

Some of the similar stocks of Inari Medical are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.